This site is intended for health professionals only

At the heart of general practice since 1960

Pfizer withdraws Exubera

Pfizer has sent a letter to healthcare professionals providing advice on transferring patients on Exubera to alternative products, following its decision to withdraw the inhaled insulin for commercial reasons.

Exubera will be available until 16 January 2008 to make the transition process easier

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say